UCLA Nov 16, 2020 Somatic Mutations in Lung Cancer Patients With HLA Supertype B44 Influence Immunotherapy Response Jun 3, 2020 BFOR Study Uses Digital Tools to Facilitate Population BRCA Screening in Ashkenazi Jewish Community Dec 9, 2019 PAK4 Inhibition Increases Anti-PD-1 Response in Mouse Models Prompting Phase I Trial Sep 30, 2019 Advanced Breast Cancer Patients Benefit From Combination Therapy Including CDK4/6 Inhibitors Jun 28, 2019 Adaptive Clinical Trial to Evaluate Glioblastoma Treatments, Biomarkers Premium Jun 2, 2019 CDK4/6 Inhibitor Boosts Overall Survival in Advanced, Premenopausal Breast Cancer Subgroup Premium Sep 13, 2018 TGen Team Hopes $2M Study Will Help Lay Path for Liquid Biopsy Monitoring in Metastatic Melanoma Premium Breaking News Ratio Therapeutics Raises $20M in Series A Financing Guardant Health, AnHeart Tx to Develop Blood- and Tissue-Based CDx for NSCLC Drug Ellipses Pharma Cleared by FDA to Open Phase I/II AML Trial Survey Reveals Changing Genetic Testing Patterns, Persistent Disparities in Precision Oncology Amgen's Lumakras Sales Increased 58 Percent in Q4 2022 Coeptis Therapeutics, University of Pittsburgh Studying SNAP-CAR Therapy in HER2-Positive Cancers
